Open Access

Virtual screening of combinatorial library of novel benzenesulfonamides on mycobacterial carbonic anhydrase II


Cite

[1] Behnke CA, Le Trong I, Godden JW, et al. Atomic resolution studies of carbonic anhydrase II. Acta Crystallogr. 2010;66:616-627.10.1107/S0907444910006554Search in Google Scholar

[2] Ceruso M, Vullo D, Scozzafava A, Supuran CT. Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties. Bioorg Med Chem. 2013;21:6929-6936.10.1016/j.bmc.2013.09.031Search in Google Scholar

[3] Covarrubias AS, Bergfors T, Jones TA, Hogbom M. Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis. J Biol Chem. 2006;281:4993-4999.10.1074/jbc.M510756200Search in Google Scholar

[4] Covarubias AS, Larsson AM, Hogbom M, et al. Structure and Function of Carbonic Anhydrases from Mycobacterium tuberculosis. J Biol Chem. 2005;280:18782-18789.10.1074/jbc.M414348200Search in Google Scholar

[5] Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT. Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes. J Med Chem. 2006;49:6177-6196.10.1021/jm051256oSearch in Google Scholar

[6] Keckesova S, Sedlarova E, Cizmarik J, et al. Antimycobacterial activity of novel derivatives of arylcarbonyloxyaminopro-panols. Ceska Slov Farm. 2009;58:203-207.Search in Google Scholar

[7] Li J, Abel R, Zhu K, et al. The VSGB 2.0 Model: A Next Generation Energy Model for High Resolution Protein Structure Modelling. Proteins 2011;79:2794-2812.10.1002/prot.23106Search in Google Scholar

[8] Lipinski C, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3-26.10.1016/S0169-409X(00)00129-0Search in Google Scholar

[9] Maresca A. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with. Bioorg Med Chem Lett. 2009;19:4929-4932.10.1016/j.bmcl.2009.07.088Search in Google Scholar

[10] Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A. 2003;100:12989-12994.10.1073/pnas.2134250100Search in Google Scholar

[11] Shelley JC, Cholleti A, Frye L, Greenwood JR, Timlin MR, Uchimaya M. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules. J Comp-Aided Mo. Design. 2007;21:681-691.Search in Google Scholar

[12] Showalter HD, Denny WA. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment. Tuberculosis (Edinb). 2008;88(1 suppl):s3- s17.10.1016/S1472-9792(08)70032-5Search in Google Scholar

[13] Supuran CT. Carbonic anhydrases - An overview. Curr Pharm Des. 2008;14:603-614.10.2174/13816120878387788418336305Search in Google Scholar

[14] Supuran CT. Carbonic Anhydrase Inhibition/Activation: Trip of a Scientist Around the World in the Search of Novel Chemotypes and Drug Targets. Curr Pharm Des. 2010;16:3233-3245.10.2174/13816121079342979720819070Search in Google Scholar

[15] Upadhayaya RS, Kulkarni GM, Vasireddy NR, Vandavasi JK, Dixit SS, Sharma V, Chattopadhyaya J. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis. Bioorg Med Chem 2009;17:4681-4692.10.1016/j.bmc.2009.04.06919457676Search in Google Scholar

[16] Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615-2623.10.1021/jm020017n12036371Search in Google Scholar

[17] Waisser K, Dolezal R, Palat K, Cizmarik J, Kaustova J. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids. Folia Microbiologica. 2006;51:21-24.10.1007/BF0293144416821706Search in Google Scholar

[18] WHO. WHO Global tuberculosis report. WHO; 2013.Search in Google Scholar

eISSN:
2453-6725
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Pharmacy, other